Bayer Aktiengesellschaft (VIE:BAYN)

Market Cap	39.39B +67.0%
Revenue (ttm)	45.58B -2.2%
Net Income	-3.62B
EPS	-3.68
Shares Out	n/a
PE Ratio	n/a
Forward PE	9.43
Dividend	0.11 (0.27%)
Ex-Dividend Date	Apr 27, 2026

Volume	n/a
Average Volume	6,242
Open	39.99
Previous Close	40.28
Day's Range	39.99 - 40.17
52-Week Range	18.66 - 49.70
Beta	n/a
RSI	47.11
Earnings Date	Mar 4, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 87,280
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BAYN

Financial Performance

In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.